4//SEC Filing
Aegerion Pharmaceuticals, Inc. 4
Accession 0000899243-16-019674
CIK 0001338042operating
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:02 PM ET
Size
8.5 KB
Accession
0000899243-16-019674
Insider Transaction Report
Form 4
Louis Roger
See Remarks
Transactions
- Award
Stock Option (right to buy)
2016-05-09+17,000→ 17,000 totalExercise: $2.46Exp: 2026-05-09→ Common Stock (17,000 underlying) - Award
Restricted Stock Units
2016-05-09+8,000→ 8,000 total→ Common Stock (8,000 underlying)
Footnotes (4)
- [F1]The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant.
- [F2]25% of the shares of common stock underlying this stock option award will vest on May 9, 2017. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through May 9, 2020, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F4]The restricted stock units will vest in three annual installments, with 33.34% of the units vesting on May 9, 2017, 33.33% of the units vesting on May 9, 2018, and 33.33% of the units vesting on May 9, 2019, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338042
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:02 PM ET
- Size
- 8.5 KB